Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Craig Jordan

Showing results (171-180 of 218) with videos related to

Pageof 22
Sort By:
Cancer Research|November 13, 2003
Distinct molecular conformations of the estrogen receptor alpha complex exploited by environmental estrogensDavid Bentrem, Jennifer E Fox, Sandra Timm Pearce, et al.
Journal of the National Cancer Institute|February 21, 2002
Effects of raloxifene after tamoxifen on breast and endometrial tumor growth in athymic miceRuth M O'Regan, Csaba Gajdos, Rita C Dardes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivoRita C Dardes, Ruth M O'Regan, Csaba Gajdos, et al.
International Journal of Oncology|October 4, 2006
Cooperative effect of gefitinib and fumitremorgin c on cell growth and chemosensitivity in estrogen receptor alpha negative fulvestrant-resistant MCF-7 cellsHong Liu, Dong Cheng, Alyssa K Weichel, et al.
Journal of the National Cancer Institute|September 27, 2014
Pharmacological relevance of endoxifen in a laboratory simulation of breast cancer in postmenopausal patientsPhilipp Y Maximov, Russell E McDaniel, Daphne J Fernandes, et al.
Breast (Edinburgh, Scotland)|August 28, 2007
Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patientsV Craig Jordan, Joan Lewis-Wambi, Helen Kim, et al.
Breast Cancer Research : BCR|December 9, 2008
Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosisJoan S Lewis-Wambi, Helen R Kim, Chris Wambi, et al.
Breast Cancer Research : BCR|June 16, 2018
Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosisJoan S Lewis-Wambi, Helen R Kim, Chris Wambi, et al.
Cancer Biology & Therapy|March 17, 2004
Estrogen receptor expression and sensitivity to paclitaxel in breast cancerMichele K Dougherty, Lisa M Schumaker, V Craig Jordan, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 25, 2003
Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cellsDebra A Tonetti, Robyn Rubenstein, Michael DeLeon, et al.
Pageof 22

Showing results (171-180 of 218) with videos related to

Sort By:
Pageof 22
Cancer Research|November 13, 2003
Distinct molecular conformations of the estrogen receptor alpha complex exploited by environmental estrogensDavid Bentrem, Jennifer E Fox, Sandra Timm Pearce, et al.
Journal of the National Cancer Institute|February 21, 2002
Effects of raloxifene after tamoxifen on breast and endometrial tumor growth in athymic miceRuth M O'Regan, Csaba Gajdos, Rita C Dardes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivoRita C Dardes, Ruth M O'Regan, Csaba Gajdos, et al.
International Journal of Oncology|October 4, 2006
Cooperative effect of gefitinib and fumitremorgin c on cell growth and chemosensitivity in estrogen receptor alpha negative fulvestrant-resistant MCF-7 cellsHong Liu, Dong Cheng, Alyssa K Weichel, et al.
Journal of the National Cancer Institute|September 27, 2014
Pharmacological relevance of endoxifen in a laboratory simulation of breast cancer in postmenopausal patientsPhilipp Y Maximov, Russell E McDaniel, Daphne J Fernandes, et al.
Breast (Edinburgh, Scotland)|August 28, 2007
Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patientsV Craig Jordan, Joan Lewis-Wambi, Helen Kim, et al.
Breast Cancer Research : BCR|December 9, 2008
Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosisJoan S Lewis-Wambi, Helen R Kim, Chris Wambi, et al.
Breast Cancer Research : BCR|June 16, 2018
Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosisJoan S Lewis-Wambi, Helen R Kim, Chris Wambi, et al.
Cancer Biology & Therapy|March 17, 2004
Estrogen receptor expression and sensitivity to paclitaxel in breast cancerMichele K Dougherty, Lisa M Schumaker, V Craig Jordan, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 25, 2003
Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cellsDebra A Tonetti, Robyn Rubenstein, Michael DeLeon, et al.
Pageof 22